ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Third Quarter Fiscal Year 2013 Financial Results  
4/18/2013 7:16:13 AM

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer therapeutics, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 26, 2013, to discuss ImmunoGen's financial results for the three-month period ended March 31, 2013 – the third quarter of the Company’s 2013 fiscal year.